Stable blue-light-emitting bionic spray essence and preparation method thereof

Abstract

The invention relates to the field of cosmetics, in particular to stable bionic spray essence with blue light and a preparation method of the stable bionic spray essence. The essence is prepared from the following components in percentage by mass: an oil phase and a water phase, the oil phase is a microemulsion phase; the oil phase comprises grease, an oil-soluble active matter, polyol, an emulsifier and water; the water phase comprises a humectant, a water-soluble active matter and water; the essence is in a blue light state; the essence is in a blue light state and can be in a spray shape; the emulsifier does not comprise PEG-60 hydrogenated castor oil. According to the technical scheme, not only can the oil-soluble component be added into the water aqua, but also the water aqua product can be in a blue light state, so that the product is higher in end and stronger in effect. Furthermore, according to the scheme, the problem can be effectively solved, the product capable of stably presenting blue light is realized, and agglomeration is avoided. According to the technical scheme, the stable bionic spray essence with blue light is developed.

Description

Technical Field

[0001] The present application relates to the field of cosmetics, and more specifically, to a stable blue-light bionic spray essence and a preparation method thereof. Background Art

[0002] Since the development of the human world, no matter how the times change, human beings' love of beauty has never changed. The dosage forms of cosmetics are also changing with each passing day. Starting from water-based products, they include lotions, toners, softeners, astringents, essences, etc.

[0003] However, common water-based products are circulated in the market as basic moisturizing products. And most of them only contain water-soluble moisturizers and water, without oil-soluble ingredients; their efficacy is greatly reduced.

[0004] This greatly limits the application of aqueous products. Summary of the invention

[0005] The purpose of the embodiments of the present application is to provide a stable blue-light bionic spray essence, which can contain water-soluble active ingredients and oil-soluble active ingredients at the same time, and the essence presents blue light and is in a spray form; while improving the efficacy of water-based cosmetics, it also improves the stability of water-based cosmetics.

[0006] In a first aspect, the present application provides a stable blue light bionic spray essence, which comprises, by mass percentage, an oil phase and a water phase;

[0007] The oil phase is a microemulsion phase;

[0008] The oil phase includes: oil, oil-soluble active ingredients, polyols, emulsifiers and water;

[0009] The aqueous phase includes: humectants, water-soluble active ingredients and water;

[0010] The essence appears in a blue light state; the essence appears in a blue light state, and the essence can be in a spray form; the emulsifier does not include PEG-60 hydrogenated castor oil.

[0011] In the above technical solution, not only can the oil-soluble ingredients be added to the aqueous solution, but the aqueous solution product can also be made to present a blue light state, making the product more high-end, more effective and more durable. Further, in the above technical solution, the oil phase is a microemulsion phase; however, conventional microemulsion technology has a fatal weakness: because the particle size range of the microemulsion phase is in the range of 10-100nm, the particles in this range will present blue light under the irradiation of light, but the nanoparticle particles in this range are very small, so it is very easy to agglomerate into large particles, which causes the blue light of the product to disappear and become an ordinary white emulsion. The above solution of the present application can effectively avoid this problem and realize a product that can stably present blue light without agglomeration. The above technical solution of the present application has developed a stable, blue-light-emitting bionic spray essence. The system has higher simplicity and versatility in operation, better stability, better universality, and can be well applied to industrial production.

[0012] In other embodiments of the present application, the oil includes: at least one of synthetic oil and / or vegetable oil.

[0013] In other embodiments of the present application, the synthetic oil includes at least one of triethylhexanoin, caprylic / capric triglyceride, isohexadecane, isododecane, isononyl isononanoate or hydrogenated polyisobutene.

[0014] In other embodiments of the present application, the plant oil includes: at least one of squalane, cetearyl alcohol, hydrogenated polydecene, stearic acid, meadowfoam seed oil, jojoba seed oil, sunflower seed oil, olive oil, camellia seed oil, scutellaria oil or camellia oil.

[0015] In other embodiments of the present application, the emulsifier includes at least one of polyglyceryl-3 diisostearate, polyglyceryl-4 isostearate, polyglyceryl-10 myristate or PPG-13-decyltetradecyl alcohol polyether-24.

[0016] In other embodiments of the present application, the oil-soluble active ingredients include: at least one of ceramides, astaxanthin, tocopherol, phytosterols, sphingolipids, phytosphingosine, tetraacetyl phytosphingosine, glycosphingolipids, stearic acid, lecithin, hydrogenated lecithin, cholesterol, VC-IP, retinol, hydroxypinacolone retinoic acid ester or coenzyme Q-10.

[0017] In other embodiments of the present application, the ceramides include at least one of ceramide EOP, ceramide NP or ceramide AP.

[0018] In other embodiments of the present application, the polyol includes at least one of glycerin, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90 or dipropylene glycol.

[0019] In other embodiments of the present application, the moisturizer includes at least one of glycerin, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90 or dipropylene glycol.

[0020] In other embodiments of the present application, the water-soluble active ingredient includes at least one of allantoin, dipotassium glycyrrhizinate, niacinamide, soluble collagen, recombinant collagen, and polypeptides.

[0021] In other embodiments of the present application, in the oil phase, the mass ratio of the emulsifier to the oil is (2:3) to (1:1).

[0022] In other embodiments of the present application, the proportion of water in the oil phase is 4.47% to 4.5%.

[0023] In other embodiments of the present application, the proportion of oil-soluble active ingredients in the oil phase is 0.9% to 1.29%.

[0024] In other embodiments of the present application, the proportion of polyols in the oil phase is 67.3% to 70.5%.

[0025] In other embodiments of the present application, the proportion of fat in the oil phase is 13.47% to 14.1%.

[0026] In other embodiments of the present application, the proportion of the emulsifier in the oil phase is 9.4% to 13.5%.

[0027] In other embodiments of the present application, in the oil phase, the mass ratios of oil, oil-soluble active ingredients, polyols, emulsifiers and water are: (0.3-0.6): (0.02-0.055): (1.5-3): (0.3-0.6): (0.1-0.2).

[0028] In other embodiments of the present application, the oil phase accounts for 2.22% to 4.455% of the essence in terms of mass percentage.

[0029] In other embodiments of the present application, in the water phase, the mass ratio of the humectant to the water-soluble active ingredient is: (7-8):1.

[0030] In other embodiments of the present application, the essence includes, by mass percentage: 2.22% to 4.455% of an oil phase; 2% to 10% of a moisturizer; 0.5% to 1% of a water-soluble active ingredient; and the balance water.

[0031] In a second aspect, the present application provides a method for preparing a stable blue light bionic spray essence, comprising:

[0032] After mixing the various raw materials of the oil phase, heating to 65°C to 85°C to obtain a dissolved oil phase mixed raw material;

[0033] Adding water dropwise to the dissolved oil phase mixed raw material to form a microemulsion phase;

[0034] The microemulsion phase is then added to the dissolved aqueous phase mixed materials.

[0035] The preparation method of the present application has higher simplicity and versatility in operation, better stability, better universality, and can be well applied to industrial production.

[0036] In other embodiments of the present application, the preparation of the aqueous phase mixed raw material includes:

[0037] After mixing the raw materials of the aqueous phase, the mixture is heated to 65°C to 85°C to obtain a dissolved aqueous phase mixed raw material.

[0038] In other embodiments of the present application, the microemulsion phase is added to the dissolved aqueous phase mixed raw material, stirred and cooled to room temperature. BRIEF DESCRIPTION OF THE DRAWINGS

[0039] In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings required for use in the embodiments will be briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present application and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without paying creative work.

[0040] Figure 1 This is a picture of the blue light bionic spray essence paste stability experiment in Example 1;

[0041] Figure 2 This is a picture of the blue light bionic spray essence stability test paste of Example 2;

[0042] Figure 3 This is a picture of the stability test paste of the blue light bionic spray essence in Example 3;

[0043] Figure 4 This is a picture of the blue light bionic spray essence stability test paste of Example 4;

[0044] Figure 5 This is a picture of the stability test paste of the blue light bionic spray essence in comparative example 1;

[0045] Figure 6 This is a picture of the stability test paste of the blue light bionic spray essence in comparative example 2;

[0046] Figure 7 This is a picture of the stability test paste of the blue light bionic spray essence in comparative example 2;

[0047] Figure 8 It is a spray comparison diagram of Examples 1-4 and Comparative Examples 1-2. DETAILED DESCRIPTION

[0048] In order to make the purpose, technical solutions and advantages of the embodiments of the present application clearer, the technical solutions in the embodiments of the present application will be clearly and completely described below. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments.

[0049] Therefore, the following detailed description of the embodiments of the present application is not intended to limit the scope of the present application for protection, but merely represents selected embodiments of the present application. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present application.

[0050] Microemulsion systems are conventionally prepared using a system containing PEG-60 hydrogenated castor oil; however, this microemulsion system is very unstable and has very strict preparation conditions, and it is almost impossible to reproduce the conventional cosmetics process preparation; this greatly limits its application in industrial applications. The inventors have found through research that this is because the addition of PEG-60 hydrogenated castor oil to the microemulsion system will cause the microemulsion system to be very unstable; it is very difficult to form a microemulsion system, and it is even more difficult to present blue light. This conventional system has relatively strict requirements on experimental conditions, so the batch stability of the experiment is not good, and it is difficult to use the simplest method to achieve a pan-blue light system. It is easy to fail in operation and form an ordinary emulsified system with larger particles.

[0051] Based on this, the embodiment of the present application provides a stable blue light bionic spray essence, which comprises, by mass percentage, an oil phase and a water phase;

[0052] The oil phase is a microemulsion phase;

[0053] The oil phase includes: oil, oil-soluble active ingredients, polyols, emulsifiers and water;

[0054] The aqueous phase includes: humectants, water-soluble active ingredients and water;

[0055] The essence appears in a blue light state; the essence appears in a blue light state, and the essence can be in a spray form.

[0056] In the above technical solution, not only can the oil-soluble ingredients be added to the aqueous solution, but the aqueous solution product can also be made to present a blue light state, making the product more high-end, more effective and more durable. Further, in the above technical solution, the oil phase is a microemulsion phase; however, conventional microemulsion technology has a fatal weakness: because the particle size range of the microemulsion phase is in the range of 10-100nm, the particles in this range will present blue light under the irradiation of light, but the nanoparticle particles in this range are very small, so it is very easy to agglomerate into large particles, which causes the blue light of the product to disappear and become an ordinary white emulsion. The above solution of the present application can effectively avoid this problem and realize a product that can stably present blue light without agglomeration. The above technical solution of the present application has developed a stable, blue-light-emitting bionic spray essence. The system has higher simplicity and versatility in operation, better stability, better universality, and can be well applied to industrial production.

[0057] Furthermore, in some embodiments of the present application, the oil comprises: at least one of synthetic oil and / or vegetable oil.

[0058] Furthermore, in some embodiments of the present application, the synthetic oil comprises at least one of triethylhexanoin, caprylic / capric triglyceride, isohexadecane, isododecane, isononyl isononanoate or hydrogenated polyisobutene.

[0059] Exemplarily, in some embodiments of the present application, the synthetic oil includes: any one of tri(ethylhexanoin)glyceryl, caprylic / capric triglyceride, isohexadecane, isododecane, isononyl isononanoate or hydrogenated polyisobutene; or in some embodiments of the present application, the synthetic oil includes: a mixture of tri(ethylhexanoin)glyceryl, caprylic / capric triglyceride, isohexadecane, isododecane, isononyl isononanoate and hydrogenated polyisobutene; the raw materials in the mixture are mixed in any proportion; or in some embodiments of the present application, the synthetic oil includes: a mixture of tri(ethylhexanoin)glyceryl and caprylic / capric triglyceride; the raw materials in the mixture are mixed in any proportion; or in some embodiments of the present application, the synthetic oil includes: a mixture of tri(ethylhexanoin)glyceryl, caprylic / capric triglyceride, isononyl isononanoate; the raw materials in the mixture are mixed in any proportion.

[0060] Furthermore, in some embodiments of the present application, the plant oil includes: at least one of squalane, cetearyl alcohol, hydrogenated polydecene, stearic acid, meadowfoam seed oil, jojoba seed oil, sunflower seed oil, olive oil, camellia seed oil, scutellaria oil or camellia oil.

[0061] For example, in some embodiments of the present application, the plant oil includes: any one of squalane, cetearyl alcohol, hydrogenated polydecene, stearic acid, white pondweed seed oil, jojoba seed oil, sunflower seed oil, olive oil, camellia seed oil, flat-core wood oil, and camellia seed oil; or in some embodiments of the present application, the plant oil includes: a mixture of squalane, cetearyl alcohol, hydrogenated polydecene, and stearic acid; the raw materials in the mixture are mixed in any proportion. Or in some embodiments of the present application, the plant oil includes: a mixture of white pondweed seed oil, jojoba seed oil, sunflower seed oil, olive oil, and camellia seed oil; the raw materials in the mixture are mixed in any proportion.

[0062] Further, in some embodiments of the present application, the emulsifier includes: at least one of polyglyceryl-3 diisostearate, polyglyceryl-4 isostearate, polyglyceryl-10 myristate or PPG-13-decyltetradecyl alcohol polyether-24.

[0063] Exemplarily, in some embodiments of the present application, the emulsifier includes: any one of polyglyceryl-3 diisostearate, polyglyceryl-4 isostearate, polyglyceryl-10 myristate or PPG-13-decyl tetradecyl alcohol polyether-24; or, in some embodiments of the present application, the emulsifier is a mixture of polyglyceryl-3 diisostearate and polyglyceryl-4 isostearate, and the raw materials in the mixture are mixed in any proportion. Or, in some embodiments of the present application, the emulsifier is a mixture of polyglyceryl-3 diisostearate, polyglyceryl-10 myristate, and PPG-13-decyl tetradecyl alcohol polyether-24, and the raw materials in the mixture are mixed in any proportion. Or, in some embodiments of the present application, the emulsifier is a mixture of polyglyceryl-4 isostearate, polyglyceryl-10 myristate, and PPG-13-decyl tetradecyl alcohol polyether-24, and the raw materials in the mixture are mixed in any proportion.

[0064] Furthermore, in some embodiments of the present application, the oil-soluble active ingredients include: at least one of ceramides, astaxanthin, tocopherol, phytosterols, sphingolipids, phytosphingosine, tetraacetyl phytosphingosine, glycosphingolipids, stearic acid, lecithin, hydrogenated lecithin, cholesterol, VC-IP, retinol, hydroxypinacolone retinoic acid ester or coenzyme Q-10.

[0065] Exemplarily, in some embodiments of the present application, the oil-soluble active substance includes: any one of ceramides, astaxanthin, tocopherol, phytosterols, sphingolipids, phytosphingosine, tetraacetyl phytosphingosine, glycosphingolipids, stearic acid, lecithin, hydrogenated lecithin, cholesterol, VC-IP, retinol, hydroxypinacolone retinoic acid ester or coenzyme Q-10; or in some embodiments of the present application, the oil-soluble active substance is: a mixture of ceramides, astaxanthin, tocopherol, phytosterols, and sphingolipids, and the raw materials in the mixture are mixed in any proportion. Or in some embodiments of the present application, the oil-soluble active substance is: a mixture of phytosphingosine, tetraacetyl phytosphingosine, glycosphingolipids, stearic acid, lecithin, hydrogenated lecithin, cholesterol, VC-IP, and retinol, and the raw materials in the mixture are mixed in any proportion.

[0066] Furthermore, in some embodiments of the present application, the ceramides include: at least one of ceramide EOP, ceramide NP or ceramide AP.

[0067] Illustratively, in some embodiments of the present application, ceramides include: any one of ceramide EOP, ceramide NP or ceramide AP; or in some embodiments of the present application, ceramides are: a mixture of ceramide EOP, ceramide NP and ceramide AP, and the raw materials in the mixture are mixed in any proportion; or in some embodiments of the present application, ceramides are: a mixture of ceramide NP and ceramide AP, and the raw materials in the mixture are mixed in any proportion.

[0068] Furthermore, in some embodiments of the present application, the polyol includes at least one of glycerol, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90 or dipropylene glycol.

[0069] For example, in some embodiments of the present application, the polyol includes any one of glycerol, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90 or dipropylene glycol. Or in some embodiments of the present application, the polyol is a mixture of glycerol, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90, and dipropylene glycol; the various raw materials in the mixture are mixed in any proportion. Or in some embodiments of the present application, the polyol is a mixture of glycerol, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8; the various raw materials in the mixture are mixed in any proportion. Or in some embodiments of the present application, the polyol is a mixture of polyethylene glycol-90 and dipropylene glycol; the various raw materials in the mixture are mixed in any proportion.

[0070] Furthermore, in some embodiments of the present application, the moisturizer includes at least one of glycerin, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90 or dipropylene glycol.

[0071] For example, in some embodiments of the present application, the moisturizer includes any one of glycerin, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90 or dipropylene glycol. Or in some embodiments of the present application, the moisturizer is a mixture of glycerin, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90 and dipropylene glycol; the raw materials in the mixture are mixed in any proportion. Or in some embodiments of the present application, the moisturizer is a mixture of glycerin, butylene glycol, panthenol, propylene glycol and polyethylene glycol-8; the raw materials in the mixture are mixed in any proportion.

[0072] Furthermore, in some embodiments of the present application, the water-soluble active ingredient includes at least one of allantoin, dipotassium glycyrrhizinate, niacinamide, soluble collagen, recombinant collagen, and polypeptides.

[0073] For example, in some embodiments of the present application, the water-soluble active substance includes: any one of allantoin, dipotassium glycyrrhizinate, niacinamide, soluble collagen, recombinant collagen or polypeptides; or the water-soluble active substance includes: a mixture of allantoin, dipotassium glycyrrhizinate, niacinamide, soluble collagen, recombinant collagen, and polypeptides; the raw materials in the mixture are mixed in any proportion. Or in some embodiments of the present application, the water-soluble active substance is: a mixture of allantoin, dipotassium glycyrrhizinate, niacinamide, and soluble collagen; the raw materials in the mixture are mixed in any proportion.

[0074] Furthermore, the essence contains structural substances that mimic human skin sebum, such as added fatty acids, ceramides, cholesterol and other substances contained in the skin; thus, it is a bionic cosmetic that is more suitable for skin use and is beneficial to skin care.

[0075] Furthermore, in some embodiments of the present application, in the oil phase, the mass ratio of the emulsifier to the oil is (2:3) to (1:1).

[0076] In the above technical solution, by setting the mass ratio of emulsifier to oil in the oil phase to (2:3) to (1:1), the essence can be formed into a stable, blue-light bionic spray essence; no agglomeration will occur, and the blue light will not disappear.

[0077] Exemplarily, in the oil phase, the mass ratio of emulsifier to oil is 2:3, 7:10, 4:5, 9:10 or 1:1.

[0078] Furthermore, in some embodiments of the present application, the proportion of water in the oil phase is 4.47% to 4.5%.

[0079] In the above technical solution, by setting the proportion of water in the oil phase to 4.47% to 4.5%, the essence can be formed into a stable, blue-light bionic spray essence; no agglomeration will occur, and the blue light will not disappear.

[0080] Illustratively, in some embodiments of the present application, the proportion of water in the oil phase is 4.47%, 4.48%, 4.49% or 4.5%.

[0081] Furthermore, in some embodiments of the present application, the proportion of oil-soluble active ingredients in the oil phase is 0.9% to 1.29%.

[0082] In the above technical solution, by setting the proportion of oil-soluble active ingredients in the oil phase to 0.9% to 1.29%, the essence can be formed into a stable, blue-light bionic spray essence; no agglomeration will occur, and the blue light will not disappear.

[0083] Illustratively, in some embodiments of the present application, the proportion of oil-soluble active ingredients in the oil phase is 0.9%, 0.91%, 0.92%, 0.93%, 0.94%, 0.95%, 0.96%, 0.97%, 0.98%, 0.99%, 1%, 1.1%, 1.11%, 1.12%, 1.15%, 1.18%, 1.2%, 1.21%, 1.22%, 1.23%, 1.24%, 1.25%, 1.26%, 1.27%, 1.28% or 1.29%.

[0084] Furthermore, in some embodiments of the present application, the proportion of polyols in the oil phase is 67.3% to 70.5%.

[0085] In the above technical solution, by setting the proportion of polyols in the oil phase to 67.3% to 70.5%, the essence can be formed into a stable, blue-light bionic spray essence; no agglomeration will occur, and the blue light will not disappear.

[0086] Illustratively, in some embodiments of the present application, the proportion of polyols in the oil phase is 67.3%, 67.5%, 67.8%, 68%, 68.2%, 68.5%, 68.6%, 68.8%, 69.2%, 69.5%, 69.8%, 70%, 70.1%, 70.2%, 70.3% or 70.5%.

[0087] Furthermore, in some embodiments of the present application, the proportion of fat in the oil phase is 13.47% to 14.1%.

[0088] In the above technical solution, by setting the proportion of oil in the oil phase to 13.47% to 14.1%, the essence can be formed into a stable, blue-light bionic spray essence; no agglomeration will occur, and the blue light will not disappear.

[0089] Illustratively, in some embodiments of the present application, the proportion of fat in the oil phase is 13.47%, 13.48%, 13.49%, 13.5%, 13.51%, 13.52%, 13.55%, 13.58%, 13.6%, 13.62%, 13.65%, 13.68%, 13.7%, 13.75%, 13.8%, 13.85%, 13.9%, 13.95%, 14.0% or 14.1%.

[0090] Furthermore, in some embodiments of the present application, the proportion of the emulsifier in the oil phase is 9.4% to 13.5%.

[0091] In the above technical solution, by setting the proportion of emulsifier in the oil phase to 9.4% to 13.5%, the essence can be formed into a stable, blue-light bionic spray essence; no agglomeration will occur, and the blue light will not disappear.

[0092] Illustratively, in some embodiments of the present application, the proportion of emulsifier in the oil phase is 9.4%, 9.45%, 9.5%, 9.55%, 9.6%, 9.65%, 9.7%, 9.75%, 9.8%, 9.9%, 9.95%, 10%, 10.5%, 10.8%, 11%, 11.5%, 11.8%, 12%, 12.5%, 12.8%, 13%, 13.2% or 13.5%.

[0093] Furthermore, in some embodiments of the present application, in the oil phase, the mass ratio of fat, oil-soluble active ingredient, polyol, emulsifier and water is: (0.3-0.6): (0.02-0.055): (1.5-3): (0.3-0.6): (0.1-0.2).

[0094] In the above technical solution, by setting the mass ratio of oil, oil-soluble active substance, polyol, emulsifier and water in the oil phase to: (0.3-0.6): (0.02-0.055): (1.5-3): (0.3-0.6): (0.1-0.2), the essence can form a stable, blue-light bionic spray essence; no agglomeration will occur, and the blue light will not disappear.

[0095] For example, in some embodiments of the present application, the mass ratio of oil, oil-soluble active substance, polyol, emulsifier and water is:

[0096] 0.3:0.02:1.5:0.3:0.1; or 0.35:0.025:1.6:0.35:0.15; or 0.4:0.03:2:0.4:0.16; or 0.5:0.04:2.5:0.5:0.18; or 0.6:0.05:2.8:0.55:0.19; or 0.58:0.055:3:0.6:0.2.

[0097] Furthermore, in some embodiments of the present application, the oil phase accounts for 2.22% to 4.455% of the essence in terms of mass percentage.

[0098] In the above technical solution, by setting the proportion of the oil phase in the essence to 2.22% to 4.455%, the essence can be formed into a stable, blue-light bionic spray essence; no agglomeration will occur, and the blue light will not disappear.

[0099] Illustratively, in some embodiments of the present application, the oil phase accounts for 2.22%, 2.25%, 2.3%, 2.35%, 2.4%, 2.45%, 2.5%, 2.55%, 2.6%, 2.7%, 2.8%, 2.9%, 3%, 3.2%, 3.5%, 3.8%, 3.9%, 4%, 4.1%, 4.2%, 4.3%, 4.4% or 4.455% in the essence by mass percentage.

[0100] Furthermore, in some embodiments of the present application, in the aqueous phase, the mass ratio of the humectant to the water-soluble active ingredient is: (7-8):1.

[0101] In the above technical solution, by setting the mass ratio of moisturizer and water-soluble active substance in the water phase to (7-8):1, the essence can form a stable, blue-light bionic spray essence; no agglomeration will occur, and the blue light will not disappear.

[0102] Illustratively, in some embodiments of the present application, in the aqueous phase, the mass ratio of the humectant to the water-soluble active ingredient is 7:1, 7.1:1, 7.2:1, 7.3:1, 7.4:1, 7.5:1, 7.6:1, 7.7:1, 7.8:1, 7.9:1 or 8:1.

[0103] Furthermore, in some embodiments of the present application, the essence comprises, by mass percentage: 2.22% to 4.455% of an oil phase; 2% to 10% of a moisturizer; 0.5% to 1% of a water-soluble active ingredient; and the balance water.

[0104] In the above technical solution, by setting the mass percentage, the essence includes: 2.22% to 4.455% of the oil phase; 2% to 10% of the moisturizer; 0.5% to 1% of the water-soluble active ingredient; and the remainder of water, so that the essence can form a stable, blue-light bionic spray essence; and no agglomeration will occur, which will not cause the blue light to disappear.

[0105] For example, in some embodiments of the present application, the essence comprises, by mass percentage:

[0106] 2.22%, 2.23%, 2.24%, 2.25%, 2.26%, 2.27%, 2.28%, 2.29%, 2.3%, 2.35%, 2.36%, 2.4%, 2.5%, 2.8%, 3%, 3.5%, 3.8%, 4%, 4.1%, 4.2%, 4.3%, 4.4%, 4.45%, 4.455% or an oil phase in a range between any two of the foregoing values;

[0107] 2%, 2.1%, 2.2%, 2.5%, 3%, 3.5%, 3.8%, 4%, 4.2%, 4.5%, 4.8%, 5%, 5.5%, 6%, 6.5%, 7%, 7.5%, 8%, 8.5%, 9%, 9.5%, 10% or a range between any two of the foregoing values ​​of moisturizer;

[0108] 0.5%, 0.51%, 0.52%, 0.55%, 0.56%, 0.57%, 0.58%, 0.59%, 0.6%, 0.62%, 0.65%, 0.68%, 0.7%, 0.72%, 0.75%, 0.78%, 0.8%, 0.85%, 0.88%, 0.9%, 0.95%, 1% or a range between any two of the foregoing water-soluble active ingredients; and the balance water.

[0109] In other optional embodiments of the present application, the water phase further includes a preservative; and the oil phase further includes a fragrance.

[0110] Further optionally, in some embodiments of the present application, the preservative includes a combination of one or more of caprylyl glycol, 1,2-hexanediol, pentylene glycol, caprylhydroxamic acid, ethylhexylglycerin, and the like.

[0111] Further optionally, in some embodiments of the present application, the fragrance includes a combination of one or more of various flavors or essential oils.

[0112] Some embodiments of the present application provide a method for preparing a stable blue light bionic spray essence, comprising:

[0113] After mixing the various raw materials of the oil phase, heating to 65°C to 85°C to obtain a dissolved oil phase mixed raw material;

[0114] Adding water dropwise to the dissolved oil phase mixed raw material to form a microemulsion phase;

[0115] The microemulsion phase is then added to the dissolved aqueous phase mixed materials.

[0116] Exemplarily, after mixing the various raw materials of the oil phase, they are heated to 65°C, 66°C, 67°C, 68°C, 69°C, 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C or a temperature range between any two of the foregoing values ​​to obtain a dissolved oil phase mixed raw material.

[0117] In the above technical solution, water is added to the dissolved oil phase mixed raw materials to form a microemulsion phase; at this time, the oil phase forms a stable microemulsion phase with a blue light; further adding water phase raw materials can further increase the efficacy of the essence, but will not change the stable microemulsion phase that has been formed in the system itself, and only has a dilution effect; the essence as a whole still presents a stable microemulsion phase with a blue light state; greatly enhancing the highlight of the product.

[0118] The preparation method of the present application has higher simplicity and versatility in operation, better stability, better universality, and can be well applied to industrial production.

[0119] In other embodiments of the present application, the preparation of the aqueous phase mixed raw material includes:

[0120] After mixing the raw materials of the aqueous phase, the mixture is heated to 65°C to 85°C to obtain a dissolved aqueous phase mixed raw material.

[0121] Exemplarily, after mixing the various raw materials of the aqueous phase, they are heated to 65°C, 66°C, 67°C, 68°C, 69°C, 70°C, 71°C, 72°C, 73°C, 74°C, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C, 81°C, 82°C, 83°C, 84°C, 85°C or a temperature range between any two of the foregoing values ​​to obtain dissolved aqueous phase mixed raw materials.

[0122] In other embodiments of the present application, the microemulsion phase is added to the dissolved aqueous phase mixed raw material, stirred and cooled to room temperature.

[0123] The features and performance of the present application are further described in detail below in conjunction with the embodiments:

[0124] Example 1

[0125] A stable blue light bionic spray essence is provided, which is prepared according to the following steps:

[0126] In the oil phase, 0.1 g of polyglyceryl-3 isostearate, 0.2 g of PPG-13-decyltetradecyl alcohol polyether-24, 0.3 g of triethylhexanoin, 0.006 g of ceramides (ceramide EOP (0.002 g), ceramide NP (0.002 g), ceramide AP (0.002 g)), 0.003 g of cholesterol, 0.003 g of sphingolipids (phytosphingosine (0.001 g), phytosphingosine (0.001 g), glycosphingolipids (0.001 g)), 0.003 g of stearic acid, 0.005 g of hydrogenated lecithin, 1.5 g of polyethylene glycol-8, and 0.001 g of flavor were weighed, and after heating at 70°C to completely dissolve, 0.1 g of water was dropped into the mixture to form a microemulsion phase. The aqueous phase weighs 5g of glycerol, 0.2g of nicotinamide, 0.5g of soluble collagen, 0.8g of octyl hydroxamic acid and water (the amount of water added is such that the whole system reaches 100g), and completely dissolves at 70°C. The oil phase is added to the aqueous phase under stirring, and cooled to room temperature under natural stirring.

[0127] Repeat the process three times to obtain a stable, highly transparent, blue-light-emitting solution. Figure 1 shown.

[0128] Example 2

[0129] A stable blue light bionic spray essence is provided, which is prepared according to the following steps:

[0130] The oil phase weighs 0.2g polyglycerol-4 isostearate, 0.4g PPG-13-decyl tetradecyl alcohol polyether-24, 0.6g tri(ethylhexanoic acid)glycerol, 0.01g ceramide NP, 0.01g cholesterol, 0.01g phytosphingosine, 0.01g lecithin, 3g polyethylene glycol-8, 0.002g essence, and after heating at 70°C to dissolve completely, 0.2g water is added dropwise to form a microemulsion phase. The water phase weighs 5g glycerol, 0.2g niacinamide, 0.2g allantoin, 0.2g dipotassium glycyrrhizinate, 0.5g soluble collagen, 0.8g octyl hydroxamic acid and water (the amount of water added makes the whole system reach 100g), and dissolves completely at 70°C. The oil phase is added to the water phase under stirring, and cooled to room temperature under natural stirring.

[0131] Repeat the process three times to obtain a stable medium-transparency blue-light solution. Figure 2 shown.

[0132] Example 3

[0133] A stable blue light bionic spray essence is provided, which is prepared according to the following steps:

[0134] The oil phase weighs 0.2g polyglycerol-3 isostearate, 0.4g PPG-13-decyl tetradecyl alcohol polyether-24, 0.6g triethylhexanoate, 0.02g ceramide NP, 0.01g cholesterol, 0.01g phytosphingosine, 0.005g VC-IP, 0.01g lecithin, 3g polyethylene glycol-8, 0.002g essence, and after heating at 60°C to dissolve completely, 0.2g water is added dropwise to form a microemulsion phase. The water phase weighs 5g panthenol, 0.2g niacinamide, and 0.8g acetyl hexapeptide-8 aqueous solution, octyl hydroxamic acid and water (the amount of water added makes the whole system reach 100g), and dissolves completely at 60°C. The oil phase is added to the water phase under stirring, and cooled to room temperature under natural stirring.

[0135] Repeat the process three times to obtain a stable, highly transparent, blue-light-emitting solution. Figure 3 shown.

[0136] Example 4

[0137] A stable blue light bionic spray essence is provided, which is prepared according to the following steps:

[0138] The oil phase weighs 0.1g polyglycerol-10 myristate, 0.3g PPG-13-decyl tetradecyl alcohol polyether-24, 0.6g tri(ethylhexanoic acid) ester, 0.02g ceramide NP, 0.01g cholesterol, 0.01g phytosphingosine, 0.005g astaxanthin, 0.01g lecithin, 3g polyethylene glycol-8, 0.002g essence, and after heating at 60°C to dissolve completely, 0.2g water is added dropwise to form a microemulsion phase. The water phase weighs 5g propylene glycol, 0.2g allantoin, 0.1g recombinant collagen, 0.8g octyl hydroxamic acid and water (the amount of water added makes the whole system reach 100g), and dissolves completely at 60°C. The oil phase is added to the water phase under stirring, and cooled to room temperature with natural stirring.

[0139] Repeat the process three times to obtain a stable, highly transparent, blue-light-emitting solution. Figure 4 shown.

[0140] Comparative Example 1

[0141] Provided is a serum prepared according to the following steps:

[0142] The oil phase weighs 0.3g Tween-60, 0.3g triethylhexanoin, 0.005g ceramide NP, 0.005g cholesterol, 0.005g phytosphingosine, 0.005g lecithin, 1.5g polyethylene glycol-8, and 0.001g essence. After heating at 70°C to dissolve completely, 0.1g water is added dropwise to form a microemulsion phase. The water phase weighs 5g glycerol, 0.01g sodium hyaluronate, 0.2g niacinamide, 0.5g soluble collagen, 0.8g octyl hydroxamic acid, and water (the amount of water added makes the whole system reach 100g), and dissolves completely at 70°C. The oil phase is added to the water phase under stirring, and cooled to room temperature under natural stirring.

[0143] Repeat 3 times to obtain a white emulsion. Figure 5 shown.

[0144] Comparative Example 2

[0145] Provided is a serum prepared according to the following steps:

[0146] The oil phase weighs 0.6g Tween-60, 0.3g triethylhexanoin, 0.005g ceramide NP, 0.005g cholesterol, 0.005g phytosphingosine, 0.005g lecithin, 1.5g polyethylene glycol-8, and 0.001g essence. After heating at 70°C to dissolve completely, 0.1g water is added dropwise to form a microemulsion phase. The water phase weighs 5g panthenol, 0.02g sodium hyaluronate, 0.2g allantoin, 0.5g acetyl hexapeptide-8, 0.8g octyl hydroxamic acid, and water (the amount of water added makes the whole system reach 100g), and dissolves completely at 70°C. The oil phase is added to the water phase under stirring, and cooled to room temperature under natural stirring.

[0147] Repeat 3 times to obtain a white emulsion. Figure 6 shown.

[0148] Comparative Example 3

[0149] Provided is an essence, which is prepared according to conventional steps in the prior art: 8 g of PEG-60 hydrogenated castor oil, 3 g of steareth-20, 2 g of polyglyceryl-2 diisostearate, 10 g of triethylhexanoin, 4 g of squalane and 4 g of vitamin E are mixed, and heated to 70° C. to completely dissolve, to obtain phase A;

[0150] Heat 20 g of water to 85°C to prepare phase B;

[0151] Add phase A to phase B under rapid stirring and continue heating to above 90°C to obtain phase C;

[0152] Phase C was poured into the rapidly stirred remaining aqueous phase, and the temperature was lowered while stirring. 8 g of glycerol, 7 g of 1,3-butanediol, and a preservative were added in sequence, and the mixture was stirred evenly to prepare a white emulsion. A blue-light emulsion could not be obtained.

[0153] The process was repeated three times, and a white emulsion was obtained each time, and a blue-light emulsion could not be achieved. This shows that the conventional system containing PEG-60 hydrogenated castor oil has very stringent requirements on the conditions for the formation of a microemulsion phase, is difficult to form stably, and is highly accidental. It cannot be universally applied in industry and has no practical application value.

[0154] 1. The blue light stability of the essences obtained in various embodiments and comparative examples was tested.

[0155] Test method: The essence prepared in each embodiment and comparative example was packaged in sample bottles, placed under room temperature, light, 45°C, -18°C, and 4°C conditions, and stability was observed regularly.

[0156] The test results are shown in the attached manual. Figure 1 ~Attached Figure 7 ; and Tables 1 to 4.

[0157] from Figure 1-Figure 7 From the comparison, it can be seen that Examples 1-4 formed a blue light transparent solution. In Example 4, the color of the overall paste was changed because of the color of astaxanthin, but it still had a blue light effect.

[0158] Table 1 Stability study data of Example 1

[0159]

[0160] Table 2: Stability study data of Example 2

[0161]

[0162] Table 3: Stability study data of Example 3

[0163]

[0164] Table 4: Stability study data of Example 4

[0165]

[0166] 2. The spraying effect of the essence obtained in each embodiment and comparative example was tested.

[0167] Test method: Put the examples and comparative examples into a superfine spray bottle to demonstrate the spray effect

[0168] The test results are shown in the attached manual. Figure 8 .

[0169] Figure 8 The spray effects of the embodiments and comparative examples are shown. It can be seen from the figure that embodiments 1-4 have very good spray effects, and the spray effects of comparative examples 1-2 are relatively poor because sodium hyaluronate is added to the aqueous phase, which makes it impossible to achieve the spray effect. Comparative example 3 also presents a relatively good spray effect because sodium hyaluronate is not added. Therefore, polysaccharides with specific properties such as sodium hyaluronate are not suitable for aqueous spray products.

[0170] In summary, the solution of the embodiment of the present application provides an aqueous product, which presents a stable blue light state and can form a fine spray; the product will not agglomerate. It can be seen that the solution of the present application has developed a stable, blue light-emitting bionic spray essence.

[0171] The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.

Claims

1. A stable blue light bionic spray essence, characterized in that: In terms of mass percentage, the essence comprises: an oil phase and a water phase; The oil phase is a microemulsion phase; The oil phase includes: oil, oil-soluble active substances, polyols, emulsifiers and water; The aqueous phase includes: a moisturizer, a water-soluble active substance and water; The essence liquid presents a blue light state, and the essence liquid can be in a spray form; The emulsifier does not include PEG-60 hydrogenated castor oil.

2. The stable blue light bionic spray essence according to claim 1, characterized in that: The oil comprises: at least one of synthetic oil and / or vegetable oil; Optionally, the synthetic oil comprises at least one of tri(ethylhexanoin)glyceryl, caprylic / capric triglyceride, isohexadecane, isododecane, isononyl isononanoate or hydrogenated polyisobutene; Optionally, the plant oil comprises at least one of squalane, cetearyl alcohol, hydrogenated polydecene, stearic acid, meadowfoam seed oil, jojoba seed oil, sunflower seed oil, olive fruit oil, camellia seed oil, scutellaria oil or camellia oil.

3. The stable blue light bionic spray essence according to claim 1, characterized in that: The emulsifier includes at least one of polyglyceryl-3 diisostearate, polyglyceryl-4 isostearate, polyglyceryl-10 myristate or PPG-13-decyltetradecyl alcohol polyether-24.

4. The stable blue light bionic spray essence according to claim 1, characterized in that: The oil-soluble active ingredients include: at least one of ceramides, astaxanthin, tocopherol, phytosterols, sphingolipids, phytosphingosine, tetraacetyl phytosphingosine, glycosphingolipids, stearic acid, lecithin, hydrogenated lecithin, cholesterol, VC-IP, retinol, hydroxypinacolone retinoic acid ester or coenzyme Q-10; Optionally, the ceramides include at least one of ceramide EOP, ceramide NP or ceramide AP.

5. The stable blue light bionic spray essence according to claim 1, characterized in that: The polyol includes at least one of glycerol, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90 or dipropylene glycol.

6. The stable blue light bionic spray essence according to claim 1, characterized in that: The moisturizing agent includes at least one of glycerin, butylene glycol, panthenol, propylene glycol, polyethylene glycol-8, polyethylene glycol-90 or dipropylene glycol.

7. The stable blue light bionic spray essence according to claim 1, characterized in that: The water-soluble active substance includes at least one of allantoin, dipotassium glycyrrhizinate, niacinamide, soluble collagen, recombinant collagen, and polypeptides.

8. The stable blue light bionic spray essence according to any one of claims 1 to 7, characterized in that: In the oil phase, the mass ratio of the emulsifier to the oil is (2:3) to (1:1); Optionally, the proportion of water in the oil phase is 4.47% to 4.5%; Optionally, the proportion of the oil-soluble active ingredient in the oil phase is 0.9% to 1.29%; Optionally, the proportion of the polyol in the oil phase is 67.3% to 70.5%; Optionally, the proportion of the oil in the oil phase is 13.47% to 14.1%; Optionally, the emulsifier accounts for 9.4% to 13.5% in the oil phase.

9. The stable blue light bionic spray essence according to any one of claims 1 to 7, characterized in that: In the oil phase, the mass ratio of the oil, the oil-soluble active substance, the polyol, the emulsifier and the water is: (0.3-0.6): (0.02-0.055): (1.5-3): (0.3-0.6): (0.1-0.2); Optionally, the oil phase accounts for 2.22% to 4.455% of the essence in terms of mass percentage; Optionally, in the aqueous phase, the mass ratio of the moisturizer to the water-soluble active ingredient is: (7-8): 1; Optionally, the essence comprises, by mass percentage: 2.22% to 4.455% of an oil phase; 2% to 10% of a moisturizer; 0.5% to 1% water-soluble active ingredient; and the balance water.

10. The method for preparing the stable blue light bionic spray essence according to any one of claims 1 to 9, characterized in that: include: After mixing the various raw materials of the oil phase, heating to 65°C to 85°C to obtain a dissolved oil phase mixed raw material; Adding water dropwise to the dissolved oil phase mixed raw material to form a microemulsion phase; Then, the microemulsion phase is added to the dissolved aqueous phase mixed raw material; Optionally, the preparation of the aqueous phase mixed raw material includes: After mixing the various raw materials of the aqueous phase, heating to 65°C to 85°C to obtain a dissolved aqueous phase mixed raw material; Optionally, the microemulsion phase is added to the dissolved aqueous phase mixed raw materials, also stirred and allowed to cool to room temperature.

Images